A double-blind trial of a new anti-inflammatory drug in the management of osteo-arthritis of the hip-joint.
D000814:Aniline Compounds / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005461:Fluorine / Q000627:therapeutic use; D006621:Hip Joint; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010003:Osteoarthritis / Q000188:drug therapy*; D010653:Phenylbutazone / Q000627:therapeutic use
D000814:Aniline Compounds; D000893:Anti-Inflammatory Agents; D009539:Nicotinic Acids; D005461:Fluorine; D010653:Phenylbutazone; D007213:Indomethacin